AN vs BIRK

AutoNation's deterministic health scores raise significant concerns, with a weak Piotroski F-Score of 3/9 indicating poor financial health, and no available Altman Z-Score limits distress risk assessment. Despite this, the company shows strong recent earnings growth (22.6% YoY) and beats on earnings surprises, supported by a bullish analyst recommendation and a forward P/E of 10.12 that appears cheap relative to sector peers. However, high leverage (Debt/Equity of 3.90), weak liquidity (Current Ratio 0.79), and declining Q/Q EPS (-8.2%) offset these positives. The stock trades below the growth-based intrinsic value of $490 but above the conservative Graham Number of $159.54, suggesting mixed valuation signals.

BIRK's deterministic scorecard shows a Piotroski F-Score of 4/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. The stock trades below the analyst target price of $59.87 and significantly above the conservative Graham Number of $29.22, suggesting valuation is driven by growth expectations. Despite strong profitability metrics like a 22.04% operating margin and 15.50% YoY revenue growth, recent quarterly earnings show deceleration with a -26.1% Q/Q EPS decline. Insider sentiment is neutral at 40/100, and technical indicators are bearish, offsetting otherwise solid fundamentals.